Files Definitive Proxy Statement for 2025 Annual Meeting of Stockholders Urges Stockholders to Vote “FOR” BOTH Neuphoria Therapeutics Nominees on WHITE Proxy Card…
TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera…
Peer-reviewed case report published in The American Journal on Addictions highlights significant clinical improvement and sustained abstinence following Nexalin’s non-invasive…
Vancouver, Canada, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…
It is with the greatest of sadness and the deepest of regret that Compassion Center announces the passing of its…
~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to…
MIAMI, Nov. 13, 2025 /PRNewswire/ -- Loosid, the leading clean and sober lifestyle brand, today announced that it has secured…
How an independent leader is transforming care for incarcerated individuals with cutting-edge technology and patient-first solutionsBIRMINGHAM, Ala.--(BUSINESS WIRE)--NaphCare, a nationwide…
BOSTON, Nov. 6, 2025 /PRNewswire/ -- Continuum Recovery Center of Colorado (CRC), a leading Denver-based outpatient addiction treatment provider, announced…
New Contract Supports Medication Fulfillment to Initial Customers in Florida and Georgia HALLANDALE BEACH, Fla., Nov. 5, 2025 /PRNewswire/ --…